We are live on ! Find out more
SIP

Stoneridge Investment Partners Portfolio holdings

AUM $152M
1-Year Est. Return 20.58%
This Fund
S&P 500
This Quarter Est. Return
+4.32%
1 Year Est. Return
+20.58%
3 Year Est. Return
+44.17%
5 Year Est. Return
+32.14%
10 Year Est. Return
+92.72%
AUM
$690M
AUM Growth
+$20M
Cap. Flow
-$5.92M
Cap. Flow %
-0.86%
Top 10 Hldgs %
18.32%
Holding
349
New
73
Increased
57
Reduced
129
Closed
89

Top Buys

Rank Stock Value
1
BMY icon
Bristol-Myers Squibb
BMY
+$12.4M
2
HSY icon
Hershey
HSY
+$8.96M
3
HST icon
Host Hotels & Resorts
HST
+$8.58M
4
TPR icon
Tapestry
TPR
+$6.04M
5
COTY icon
Coty
COTY
+$5.69M

Top Sells

Rank Stock Value
1
STJ
St Jude Medical
STJ
+$9.7M
2
GM icon
General Motors
GM
+$6.74M
3
WHR icon
Whirlpool
WHR
+$6.34M
4
CI icon
Cigna
CI
+$4.77M
5
JPM icon
JPMorgan Chase
JPM
+$4.71M

Sector Composition

Rank Sector Weight
1 Healthcare 14.65%
2 Financials 14.42%
3 Technology 14.14%
4 Consumer Discretionary 12.17%
5 Industrials 11.43%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
STML
226
DELISTED
Stemline Therapeutics, Inc.
STML
$365K 0.05%
33,725
-165
-0.5% -$1.34K
PRTK
227
DELISTED
Paratek Pharmaceuticals, Inc.
PRTK
$361K 0.05%
27,736
+4,068
+17% +$53.9K
RRTS
228
DELISTED
RoadRunner Transportation Systems, Inc.
RRTS
$357K 0.05%
1,789
-8
-0.4% -$1.62K
IL
229
DELISTED
IntraLinks Holdings Inc.
IL
$357K 0.05%
+35,446
New +$300K
TPST icon
230
Tempest Therapeutics
TPST
$16M
$356K 0.05%
17
– –
ARQL
231
DELISTED
Arqule Inc
ARQL
$337K 0.05%
188,081
-944
-0.5% -$1.5K
TUBE
232
DELISTED
TubeMogul, Inc.
TUBE
$335K 0.05%
+35,704
New +$360K
HUBG icon
233
HUB Group
HUBG
$2.94B
$318K 0.05%
+15,610
New +$318K
ZAGG
234
DELISTED
ZAGG Inc Common Stock (Delaware)
ZAGG
$302K 0.04%
37,273
-178
-0.5% -$1.25K
MOBL
235
DELISTED
MobileIron, Inc.
MOBL
$296K 0.04%
+107,582
New +$333K
SYNA icon
236
Synaptics
SYNA
$4.15B
$285K 0.04%
+4,867
New +$267K
DFRG
237
DELISTED
Del Frisco's Restaurant Group, Inc. Common Stock
DFRG
$285K 0.04%
21,171
-99
-0.5% -$1.47K
ELNK
238
DELISTED
EarthLink Holdings Corp.
ELNK
$282K 0.04%
+45,516
New +$295K
FLXN
239
DELISTED
Flexion Therapeutics, Inc.
FLXN
$271K 0.04%
+13,857
New +$234K
MGNI icon
240
Magnite
MGNI
$3.48B
$259K 0.04%
+31,305
New +$333K
ELGX
241
DELISTED
Endologix Inc
ELGX
$258K 0.04%
2,018
-9
-0.4% -$1.15K
NBSE
242
DELISTED
NeuBase Therapeutics, Inc. Common Stock
NBSE
$219K 0.03%
193
-1
-0.5% -$1.08K
XOM icon
243
ExxonMobil
XOM
$655B
$207K 0.03%
2,374
-4,184
-64% -$371K
DRRX
244
DELISTED
DURECT Corp
DRRX
$202K 0.03%
14,544
-66
-0.5% -$1.08K
GNMK
245
DELISTED
GenMark Diagnostics, Inc
GNMK
$201K 0.03%
17,044
-14,110
-45% -$136K
TUES
246
DELISTED
Tuesday Morning Corp
TUES
$199K 0.03%
33,206
-148
-0.4% -$1.05K
LAB icon
247
Standard BioTools
LAB
$307M
$194K 0.03%
24,280
-116
-0.5% -$1.06K
BBW icon
248
Build-A-Bear
BBW
$456M
$189K 0.03%
18,214
-87
-0.5% -$1.06K
CLDX icon
249
Celldex Therapeutics
CLDX
$3.34B
$187K 0.03%
3,092
-14
-0.5% -$872
HLIT icon
250
Harmonic Inc
HLIT
$1.27B
$178K 0.03%
30,042
-17,378
-37% -$69.3K
8 9
10
11 12

Similar funds

HWM
Horizons Wealth Management Asheville, North Carolina $152M AUM 9.43% 1-Year Est. Return
SGM
Sellaronda Global Management New York $152M AUM 2.1% 1-Year Est. Return
CMMS
Comprehensive Money Management Services Coral Gables, Florida $152M AUM 20.08% 1-Year Est. Return
FHC
Forest Hill Capital Little Rock, Arkansas $152M AUM 64.38% 1-Year Est. Return
RHAM
Round Hill Asset Management Pasadena, California $153M AUM 6.67% 1-Year Est. Return
II
Ibex Investors Denver, Colorado $152M AUM 19.17% 1-Year Est. Return
APW
Atlantic Private Wealth Chapel Hill, North Carolina $153M AUM 15.75% 1-Year Est. Return
BCI
Blue Capital Inc Omaha, Nebraska $153M AUM 28.69% 1-Year Est. Return

Stoneridge Investment Partners's Q3 2016 Portfolio in Review

As of Q3 2016, Stoneridge Investment Partners held 349 positions worth $690M, up 3% from $670M the previous quarter. Its ten largest holdings account for 18% of the portfolio.

Stoneridge Investment Partners's Q3 2016 filing shows 73 new, 57 increased, 129 reduced and 89 closed positions. Its largest new stake was Bristol-Myers Squibb: 193,005 shares worth $10.4M. The largest sale was St Jude Medical, an estimated $9.7M.

By sector, the portfolio is most concentrated in Healthcare at 15% of assets, down from 16% a quarter earlier, followed by Financials and Technology.

  • Stoneridge Investment Partners's largest Q3 2016 buy was Bristol-Myers Squibb: 193,005 shares worth $10.4M.
  • Stoneridge Investment Partners added most to Philip Morris in Q3 2016, an estimated $5.27M increase.
  • Stoneridge Investment Partners's biggest Q3 2016 reduction was St Jude Medical, cutting an estimated $9.7M.
  • Stoneridge Investment Partners fully exited Cigna in Q3 2016, selling an estimated $4.77M.
  • Stoneridge Investment Partners's ten largest holdings make up 18% of its $690M portfolio in Q3 2016.
  • Stoneridge Investment Partners opened 73 new positions and closed 89 in Q3 2016.
  • Stoneridge Investment Partners's portfolio value rose 3% quarter-over-quarter to $690M.

Based on Stoneridge Investment Partners's 13F filing for Q3 2016, filed 28 Oct 2016.